Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5871 posts found.

Merck elects Isabel De Paoli as CSO

September 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
Appointment
amgen_hq

Amgen’s Kyprolis disappoints in Phase III trial

September 27, 2016 Manufacturing and Production, Research and Development Amgen, Kyprolis, phase III

Amgen was relying on the results of the trial to justify its $10.4 billion purchase of Onyx Pharmaceuticals, acquiring Kyprolis …
News
cancer-389921_960_720

Kite Pharma flying high after promising Car-T trial

September 27, 2016 Manufacturing and Production, Research and Development Cancer, Cart-T, kite pharma

Cart-T cell drugs are made by genetically altering patients’ T-cells to add a component of antibodies that make them better …
News
heather_bresch_2

Price-hiked EpiPen profits 66% higher than Mylan CEO claimed

September 27, 2016 Business Services, Manufacturing and Production, Sales and Marketing Heather Bresch, Mylan, epipen

In the latest development in the Mylan EpiPen scandal, it has been discovered that CEO Heather Bresch lied to US …
News

Sanofi secures $43 million government funding for zika vaccine development

September 27, 2016 Manufacturing and Production, Research and Development BARDA, Sanofi, Zika

The US Department of Health and Human Services approved $43.18 million to fund Sanofi’s development of a zika vaccine, the …
News
jj_2johnson_and_johnson

Johnson & Johnson’s Stelara receives FDA approval

September 27, 2016 Manufacturing and Production, Research and Development Janssen Biotech, Johnson & Johnson, Stelara

The drug is approved for use to treat the skin condition scaly plaque psoriasis and a type of arthritis associated …
News
biogen_austria_238

Biogen closes in on bringing muscular atrophy preventing drug to market

September 26, 2016 Manufacturing and Production, Research and Development Biogen, EMA, FDA, Nusinersen

Biogen has applied for Priority Review, which, if granted, would shorten the review period necessary for nusinersen. They also plan …
News

CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) …
News
Press release

Merck elects Isabel De Paoli as CSO

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday (and print day for the Pharmafocus October edition!) and its been a pretty explosive week, from new and …
News
shutterstock_359806121

DNA damage response biotech launches with £25m funding

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding

Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …
News
un_assembly

193 countries sign UN declaration to fight drug-resistant infection

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeremy Hunt, UN, drug-resistant infection

A historic UN declaration to fight drug-resistant infection across the globe has been signed by 193 countries at the United …
News
gilead-sciences

Gilead terminates Phase II/III study for ulcerative colitis antibody

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, ulcerative colitis

Gilead has put the brakes on a Phase II/III study of its anti-MMP9 antibody GS-5745 for the treatment of ulcerative …
News

AZ withdraws European filing for ovarian cancer therapy

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, cediranib, ovarian cancer

AstraZeneca is no longer seeker European approval for its oral multi-VEGF receptor inhibitor cediranib for treatment of ovarian cancer after withdrawing …
News
heather_bresch

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026